Helius Medical Technologies is trading at $3.05, up 5.75% in after-hours trading on September 23, 2026, with no clear catalyst identified.

  • It closed the regular session at $2.88, down 11.93%.
  • No September 23 company-specific press release, earnings update, financing announcement, or regulatory catalyst appears on the official releases page; the latest listed release was August 21, 2026.
  • Broader markets declined sharply, but the after-hours rebound does not establish a clear macro-driven cause.